थेमीस मिडकेयर

बीएसई: 530199  |  NSE: THEMISMED  |  ISIN: INE083B01016  |  Pharmaceuticals

खोजें थेमीस मिडकेयर कनेक्शन Mar 16
अध्यक्षीय भाषण साल : Mar '18

Dear Stakeholders,

I have pleasure in once again communicating to you as Managing Director & CEO of your Company. The Management, as always, continues to enjoy your confidence as we steer Themis Medicare Limited on a path of growth. I hope you will continue to extend your support as we face new challenges, take new initiatives and sustain the momentum that has been built over the past decades. As we ended the year under review, your Company completed 48 years of serving patients in India. The year gone by has been a challenging, exciting and at times a stressful one, but has been underlined by a deep sense of satisfaction. Your Company is laying a strong foundation to build a legacy for the future to provide quality affordable products for our customers. New avenues for growth and profitability are being explored in line with the opportunities thrown up by the economic ecosystem in the country and abroad.

The Goods and Service Tax (GST), the biggest indirect tax reform of India, was rolled-out effective from July 1, 2017 which impacted all areas of business across various sectors including the pharmaceutical industry. While your Company was swift and smooth in transitioning to the new tax regime, given the backdrop of this large transition that the country underwent, the operating environment for your Company during the year remained challenging and your Company''s Sales were impacted for a period of 60-90 days. Nevertheless, your Company has reported below financial figures.

During the year under review, your Company has achieved turnover of Rs. 21,170.67 lakhs as compared to Rs. 22,614.85 lakhs during last financial year. Your Company has earned a net profit after tax of Rs. 914.54 lakhs for the year as compared to net profit after tax of Rs. 1,479.74 lakhs during the previous financial year.

Besides our customers and employees, we are proud to be continuing our contribution to the society in which we live.

We believe that regulatory approvals are business driving factors. The year under review was challenging with respect to regulatory inspections at two of our locations viz. Hyderabad and Hardwar. API facility at Hyderabad faced a stringent EDQM (European Directorate for Quality of Medicines) re-inspection and our formulation unit at Hardwar also went through equally stringent EU GMP (European Good Manufacturing Practices) inspection. The EDQM inspection at Hyderabad was successfully carried out in December 2017 and we have already received approval and certificate for the same. The EU GMP inspection at Hardwar was conducted by Medicines Authority Malta in the month of January 2018. Both the inspections challenged our GMP and Quality operations critically and the inspectors crucially went through our products, processes and systems to finally grant us approval. The certificate of EU GMP at Hardwar is expected shortly. We believe that Quality at Themes Medicare is a continuing journey towards perfection and we shall strive for the same.

Introduction of a dedicated fermentation block and introduction of new product line in our Vapid Unit is expected to bring in promising growth and increase in your Company''s API Business.

Our focus will continue to be on delivering results on our promise of unwavering commitment to our shareholders. We will reciprocate the trust placed in us by creating long-term value for your investment.

I thank you for your continued encouragement as always and look forward to your constant support in our journey of charting success. I take this opportunity to place on record my acknowledge and gratitude to our other stakeholders like customers, suppliers, Government agencies, foreign collaborators and of course employees for their support and cooperation which I hope will continue going forward.

Yours sincerely,


Dr. Sachin D. Patel

Managing Director & CEO

स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `60.18 Cr की बिकवाली की
  • MARKET CUES : DIIs ने कैश में `425.98 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `1569.80 Cr की बिकवाली की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `528.06 Cr की बिकवाली
  • MARKET CUES : इंडेक्स ऑप्शंस में `720.14 Cr की बिकवाली
  • MARKET CUES : स्टॉक फ्यूचर्स में `367.32 Cr की बिकवाली
  • MARKET CUES : स्टॉक ऑप्शंस में `45.72 Cr की खरीदारी
  • MPC MEET ON CREDIT POLICY : आज क्रेडिट पॉलिसी का एलान
  • JEFFERIES ON GODREJ PROPERTIES : Buy रेटिंग, लक्ष्य बढ़ाकर `1,040/Sh
  • HDFC : आज से खुलेगा QIP, फ्लोर प्राइस `1,838.94/Sh

अभी देखें

मार्केट काउंटडाउन




(August 06, 2018)

AT (Rs)






Super Combo

Powerful mix of both trader and investor packs with timely expert advice.


Designed especially for traders looking to tap the profit opportunities of volatile markets.


For all investors looking to unearth stocks that are poised to move.